Actively Recruiting
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Led by Takeda · Updated on 2025-09-09
70
Participants Needed
13
Research Sites
220 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main aim is to check how effective BV is for treating adults with HL. Study medication will be prescribed according to the clinic's standard practice. Participants will visit the study clinic 5 times, once every 12 weeks. When study treatment has completed, a follow-up visit will be scheduled every 3 months during the first year and every 4-6 months during the next year.
CONDITIONS
Official Title
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult participant aged 18 years or older
- Have undergone or are a candidate for autologous stem cell transplant (ASCT)
- Enrolled in the BV Hodgkin Lymphoma National Drug Program and receiving treatment according to guidelines
You will not qualify if you...
- Currently participating or planning to participate in any interventional clinical trial
- Any other reason deemed by the Investigator that makes the participant unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Wroclaw, Dolnoslskie, Poland, 50-556
Actively Recruiting
2
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu
Poznan, Greater Poland Voivodeship, Poland, 61-848
Actively Recruiting
3
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Oddzial w Krakowie
Krakow, Lesser Poland Voivodeship, Poland, 31-115
Actively Recruiting
4
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie
Krakow, Lesser Poland Voivodeship, Poland, 31-501
Actively Recruiting
5
Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli
Lublin, Lublin Voivodeship, Poland, 20-090
Actively Recruiting
6
NU-MED Specjalistyczny Szpital Onkologiczny Tomaszow Mazowiecki
Tomaszow Mazowiecki, Masovian Voivodeship, Poland, 97-200
Actively Recruiting
7
Uniwersyteckie Centrum Kliniczne WUM
Warsaw, Masovian Voivodeship, Poland, 02-097
Actively Recruiting
8
Instytut Hematologii i Transfuzjologii
Warsaw, Masovian Voivodeship, Poland, 02-776
Actively Recruiting
9
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Warsaw, Masovian Voivodeship, Poland, 02-781
Actively Recruiting
10
Uniwersyteckie Centrum Kliniczne, Gdansk
Gdansk, Pomeranian Voivodeship, Poland, 80-214
Actively Recruiting
11
Samodzielny Publiczny Szpital Kliniczny im. Andrzeja Mieleckiego Slskiego Uniwersytetu Medycznego w Katowicach
Katowice, Slskie, Poland, 40-027
Actively Recruiting
12
Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warminsko - Mazurskim Centrum Onkologii w Olsztynie
Olsztyn, Warmian-Masurian Voivodeship, Poland, 10-228
Actively Recruiting
13
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii, im. M. Kopernika w Lodzi
Lodz, Łódź Voivodeship, Poland, 93-513
Actively Recruiting
Research Team
T
Takeda Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here